BALSALAZIDE DISODIUM
| Brand name | GIAZO |
|---|---|
| Active ingredient | BALSALAZIDE DISODIUM |
| Strength | 1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2012 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 8497256 | June 2031 | use U-1229 |
| 7452872 | August 2026 | use U-1229 |
| 7625884 | August 2026 | use U-1229 |
| 9192616 | August 2026 | use U-1229 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.